309 related articles for article (PubMed ID: 21365223)
1. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
Latek D; Kolinski M; Ghoshdastider U; Debinski A; Bombolewski R; Plazinska A; Jozwiak K; Filipek S
J Mol Model; 2011 Sep; 17(9):2353-66. PubMed ID: 21365223
[TBL] [Abstract][Full Text] [Related]
2. Ligand-specific homology modeling of human cannabinoid (CB1) receptor.
Ai R; Chang CE
J Mol Graph Model; 2012 Sep; 38():155-64. PubMed ID: 23079645
[TBL] [Abstract][Full Text] [Related]
3. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.
McAllister SD; Hurst DP; Barnett-Norris J; Lynch D; Reggio PH; Abood ME
J Biol Chem; 2004 Nov; 279(46):48024-37. PubMed ID: 15326174
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis.
Tuccinardi T; Ferrarini PL; Manera C; Ortore G; Saccomanni G; Martinelli A
J Med Chem; 2006 Feb; 49(3):984-94. PubMed ID: 16451064
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor.
Jakowiecki J; Filipek S
J Chem Inf Model; 2016 Dec; 56(12):2457-2466. PubMed ID: 27966915
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors.
Reggio PH
Curr Pharm Des; 2003; 9(20):1607-33. PubMed ID: 12871061
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.
Ji B; Liu S; He X; Man VH; Xie XQ; Wang J
ACS Chem Neurosci; 2020 Apr; 11(8):1139-1158. PubMed ID: 32196303
[TBL] [Abstract][Full Text] [Related]
9. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region.
McAllister SD; Rizvi G; Anavi-Goffer S; Hurst DP; Barnett-Norris J; Lynch DL; Reggio PH; Abood ME
J Med Chem; 2003 Nov; 46(24):5139-52. PubMed ID: 14613317
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
11. Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study.
Montero C; Campillo NE; Goya P; Páez JA
Eur J Med Chem; 2005 Jan; 40(1):75-83. PubMed ID: 15642412
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
Calik MW; Carley DW
PLoS One; 2014; 9(10):e111412. PubMed ID: 25350456
[TBL] [Abstract][Full Text] [Related]
13. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
Pandey P; Roy KK; Doerksen RJ
J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors and their ligands: ligand-ligand and ligand-receptor modeling approaches.
Reggio PH
Handb Exp Pharmacol; 2005; (168):247-81. PubMed ID: 16596777
[TBL] [Abstract][Full Text] [Related]
15. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
16. Computational investigation on the binding modes of Rimonabant analogs with CB1 and CB2.
Liu C; Yuan C; Wu P; Zhu C; Fang H; Wang L; Fu W
Chem Biol Drug Des; 2018 Sep; 92(3):1699-1707. PubMed ID: 29797785
[TBL] [Abstract][Full Text] [Related]
17. A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis.
Durdagi S; Papadopoulos MG; Zoumpoulakis PG; Koukoulitsa C; Mavromoustakos T
Mol Divers; 2010 May; 14(2):257-76. PubMed ID: 19536636
[TBL] [Abstract][Full Text] [Related]
18. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
Bhattacharya S; Hall SE; Li H; Vaidehi N
Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
[TBL] [Abstract][Full Text] [Related]
19. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
20. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]